Liquidia Corporation (LQDA)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
Liquidia Corporation Struggles in Challenging Business Environment with -15.466% Revenue Decrease
Liquidia Corporation Makes Striking Turnaround with Exceptional Q1 2023 Financial Results
Vanishing Losses at LQDA in the fourth quarter of 2022
A deficit of $-0.14 per Share at the company in the third quarter of 2022 earnings season